Effectiveness and safety of the bevacizumab and erlotinib combination versus erlotinib alone in EGFR mutant metastatic non-small-cell lung cancer: systematic review and meta-analysis.

Published in:

Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2023.1335373

By:

• Motta-Guerrero, Rodrigo;
• Garrido-Lecca, Alejandro Leon;
• Failoc-Rojas, Virgilio E.;
• Calle-Villavicencio, Ana;
• Villacorta-Carranza, Robert;
• Huerta-Collado, Yesenia;
• Torres-Mera, Alicia;
• Valladares-Garrido, Mario J.;
• Rivera-Francia, Víctor;
• Carracedo, Carlos;
• Raez, Luis

Publication type:

Article